These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10359099)

  • 1. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice.
    Dyson PJ; Elliott JI
    Eur J Immunol; 1999 May; 29(5):1456-66. PubMed ID: 10359099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
    Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
    J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
    Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
    J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.
    Sheard MA; Sharrow SO; Takahama Y
    Scand J Immunol; 2000 Dec; 52(6):550-4. PubMed ID: 11119259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
    Waanders GA; Lees RK; Held W; MacDonald HR
    Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro negative selection of viral superantigen-reactive thymocytes by thymic dendritic cells.
    Ferrero I; Anjuère F; MacDonald HR; Ardavín C
    Blood; 1997 Sep; 90(5):1943-51. PubMed ID: 9292528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen.
    Aude-Garcia C; Attinger A; Housset D; MacDonald HR; Acha-Orbea H; Marche PN; Jouvin-Marche E
    Mol Immunol; 2000 Nov; 37(16):1005-12. PubMed ID: 11395139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
    Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
    J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
    Okamoto M; Kimura S; Katagiri M
    Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
    Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
    J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell repertoire and clonal deletion of Mtv superantigen-reactive T cells in mice lacking CD4 and CD8 molecules.
    Penninger JM; Schilham MW; Timms E; Wallace VA; Mak TW
    Eur J Immunol; 1995 Jul; 25(7):2115-8. PubMed ID: 7621886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
    Maillard I; Xenarios I; Diggelmann H; Orbea HA
    Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
    Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
    J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of T and B lymphocyte activation in nonobese diabetic mice.
    Chiu PP; Jevnikar AM; Danska JS
    J Immunol; 2001 Dec; 167(12):7169-79. PubMed ID: 11739540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.
    Krummenacher C; Diggelmann H; Acha-Orbea H
    J Virol; 1996 May; 70(5):3026-31. PubMed ID: 8627779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.